Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges

Zhenyu Nie1, Mei Chen1, Yuanhui Gao1

  • 1Central Laboratory, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, China.

Insights

Ferroptosis, a unique cell death process, impacts cancer development and treatment. Understanding its role may overcome drug resistance and lead to new cancer therapies.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Ferroptosis is a regulated cell death characterized by iron accumulation and lipid peroxidation.
  • Its metabolic features are crucial for evaluating disease states, particularly in tumors.
  • Ferroptosis influences tumor progression, metastasis, and response to therapies.

Purpose of the Study:

  • To review the intricate relationship between ferroptosis and cancer drug resistance.
  • To summarize current knowledge on aberrant ferroptosis in various cancer types.
  • To explore strategies targeting ferroptosis for improved cancer treatment outcomes.

Main Methods:

  • Literature review of studies on ferroptosis and cancer.
  • Analysis of molecular mechanisms linking ferroptosis to drug resistance.
  • Synthesis of research progress and challenges in overcoming treatment resistance.

Main Results:

  • Ferroptosis plays a significant role in regulating tumor development, metastasis, and therapeutic responses.
  • Drug resistance remains a major challenge in cancer chemotherapy.
  • Aberrant ferroptosis is observed across different cancer types, contributing to treatment failure.

Conclusions:

  • Targeting ferroptosis presents a promising strategy to overcome cancer drug resistance.
  • Further research into ferroptosis mechanisms can unveil novel therapeutic targets for cancer treatment.
  • Understanding and manipulating ferroptosis is key to improving patient outcomes in oncology.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K